|
Sign In to gain access to subscriptions and/or personal tools.
|
Journal of Parenteral and Enteral Nutrition, Vol. 29, No. 1 suppl,
S57-S61 (2005)
DOI: 10.1177/01486071050290S1S57
Preoperative Immunonutrition: Cost-Benefit Analysis
Marco Braga, MD* and
Luca Gianotti, MD, ScD
From the * Department of Surgery, Vita-Salute San
Raffaele University, Milan, Italy; and the
Department of Surgery, Milano-Bicocca
University, Milan, Italy
Correspondence: Marco Braga, MD, Department of Surgery, San Raffaele Hospital
Via Olgettina 60, 20132 Milan, Italy. Electronic mail may be sent to
braga.marco{at}hsr.it.
Background: To evaluate whether preoperative immunonutrition might
lead to a savings in patient care. Data on resources consumed to treat
postoperative complications are scanty, but morbidity costs continue to be a
major burden for any health care system. A recent randomized clinical trial
carried out in well-nourished patients with gastrointestinal cancer showed
that a 5-day preoperative oral immunonutrition reduced postoperative morbidity
compared with conventional treatment (no supplementation). Methods:
The abovementioned trial was the basis for the economic evaluation.
In-hospital related costs of routine surgical care and costs of nutrition were
calculated. Estimates of complication costs were based on both resources used
for treatment and additional length of hospital stay. Cost comparison and
cost-effectiveness analysis were then carried out. Results: Total
cost of nutrition was 3407 in the conventional group and 14,729
in the preoperative group. In patients without complication, the cost of
in-hospital routine care was similar in both groups. The mean cost of
complication was 6178 in the conventional group and 4639 in the
preoperative group (p = .05). Total cost of patients with
complications was 535,236 in the conventional group and 334,148
in the preoperative group. Total costs consumed 93% of the
diagnosis-related-group (DRG) reimbursement rate in the conventional group and
78% in the preoperative group. Cost-effectiveness was 6245 for the
conventional group and 2985 for the preoperative group.
Conclusions: The costs of postoperative morbidity consumed a large
amount of the DRG reimbursement rate. Preoperative immunonutrition was
cost-effective in our series.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Matzi, J. Lindenmann, A. Muench, J. Greilberger, H. Juan, R. Wintersteiger, A. Maier, and F. M. Smolle-Juettner
The impact of preoperative micronutrient supplementation in lung surgery. A prospective randomized trial of oral supplementation of combined {alpha}-ketoglutaric acid and 5-hydroxymethylfurfural
Eur. J. Cardiothorac. Surg.,
November 1, 2007;
32(5):
776 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Sax
Immunonutrition and Upper Gastrointestinal Surgery: What Really Matters
Nutr Clin Pract,
October 1, 2005;
20(5):
540 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Zaloga
Improving Outcomes With Specialized Nutrition Support
JPEN J Parenter Enteral Nutr,
January 1, 2005;
29(1_suppl):
S49 - S52.
[Full Text]
[PDF]
|
 |
|
|